Earnings Call/Transcript
Sagility Earnings Call Transcript Filed
Sagility filed the transcript of its Q2 FY27 earnings call held on October 22, 2026, covering financial performance, business outlook, acquisitions and growth initiatives.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
3
Bullish
6
Bearish
37
Neutral
3
Bullish
6
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone


Earnings Call/Transcript
Sagility filed the transcript of its Q2 FY27 earnings call held on October 22, 2026, covering financial performance, business outlook, acquisitions and growth initiatives.
Public Notice/Press Release
Sagility published newspaper advertisements on October 24, 2026, regarding its unaudited financial results for the quarter and half year ended September 30, 2026.
Regulatory/Compliance Filing
Sagility Ltd informs shareholders that the Board declared an interim dividend of Rs.0.15/share for FY2026-27 (record date: 2026-10-30) and provides details on TDS rates, exemptions and required documents/forms.
IT - Services
IT Enabled Services
19,662 Cr
Moderate Risk
19.2
30.9
1.1
2.1
57.18
35.82
Sales CAGR
Profit CAGR
ROE
ROCE
Sagility Ltd (SAGILITY) is currently trading at 42.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sagility Limited is a technology-enabled, pure-play healthcare services company serving U.S. health insurance payers, hospitals, physicians, diagnostic companies, medical-device businesses, and pharmacy benefit managers. Its offerings cover benefits administration, clinical services, payment integrity, revenue-cycle management, care management, quality, coding, and healthcare-focused technology-enabled operations. Q2 FY27 revenue rose 22.5% year over year in rupee terms and 12.2% in constant currency to INR 20,321 million, while adjusted EBITDA margin reached 26.3%, the highest in six quarters. Strong operating efficiency, favourable geographic mix, cost discipline, and foreign-exchange benefits supported the performance despite wage increases. Sagility Limited is deliberately broadening beyond its historically payer-heavy model. Providers contributed 10.1% of Q2 revenue, and the Chirok acquisition adds mid-cycle revenue-cycle capabilities, physician-group relationships, coding expertise, and value-based-care exposure intended to accelerate provider growth and enable cross-selling. The company’s AI strategy is becoming more operational and commercially relevant, with agentic workflows being implemented for claims adjudication and denial management. Management is simultaneously guiding for low-double-digit organic constant-currency growth and raising FY27 adjusted EBITDA margin guidance from 24% to 25%-26%. Balance-sheet flexibility has improved materially, with Sagility Limited moving from INR 1,962 million net debt at FY26-end to INR 1,127 million net cash at September 2026. H1 free cash flow was INR 5,176 million, supporting debt repayment, acquisitions, technology investment, and shareholder distributions.
Over the past 52 weeks, Sagility Ltd has traded between a low of ₹35.82 and a high of ₹57.18. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sagility Ltd has a market capitalization of approximately 20,920.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sagility Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.38 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 20,920.86 Cr, Sagility Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sagility Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sagility Ltd is 20.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Sagility held its Q2 FY27 earnings webinar on October 22, 2026.
Sagility’s board meeting is scheduled for October 22, 2026 to consider and approve unaudited results for the quarter and half-year ended September 30, 2026.
The Sagility India IPO closed at an overall subscription of 3.2 times on November 7, 2024.
The consideration is up to $30 million, with $17.5 million upfront and $12.5 million contingent on future performance.